Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ribavirin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 5 and over
Sponsor: Other
Protocol IDs: ID03-0010, NCT00500578
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 25 to 75
Sponsor: Other
Protocol IDs: O2006-415, NCT00375661
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Phase: Phase IV
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: KMUH-IRB-960043, NCT00834860
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1379.00, FHCRC-1379.00, NCI-G01-1929, CDR0000068540, NCT00014391
Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 1290.00, FHCRC-1290.00, NCI-G01-1939, CDR0000068593, NCT00016081
TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 and over
Sponsor: Other
Protocol IDs: 2323.00, 6895, NCT00867139
Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Ribavirin-002, NCT01056523
A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CR0620KB, REC:06-112, NCT00559091
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P7977-2025, NCT01559844
Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-150, NCT01721525
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Completed
Age: No age specified
Sponsor: NCI, Other
Protocol IDs: VICC MEL0651, VU-VICC-MEL-0651, VU-VICC-060614, NCT00897312
Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 to 59
Sponsor: Other
Protocol IDs: 10-218, NCT01268579
Start Over